A carregar...
Qualitative transcriptional signature for predicting pathological response of colorectal cancer to FOLFOX therapy
FOLFOX (5‐fluorouracil, leucovorin and oxaliplatin) is one of the main chemotherapy regimens for colorectal cancer (CRC), but only half of CRC patients respond to this regimen. Using gene expression profiles of 96 metastatic CRC patients treated with FOLFOX, we first selected gene pairs whose within...
Na minha lista:
| Publicado no: | Cancer Sci |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6942442/ https://ncbi.nlm.nih.gov/pubmed/31785020 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14263 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|